US Stock MarketDetailed Quotes

ALGS Aligos Therapeutics

Watchlist
  • 17.750
  • +0.420+2.42%
Close Feb 26 16:00 ET
  • 17.890
  • +0.140+0.79%
Post 18:36 ET
63.69MMarket Cap-2.45P/E (TTM)

Aligos Therapeutics Key Stats

Aligos Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 333.330K--
--2024/Q4-- / 433.330K--
Nov 6, 20242024/Q31.269M / 333.330K--
Aug 6, 20242024/Q21.061M / 0.000--
May 7, 20242024/Q1986.000K / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 333.330K--
--2024/Q4-- / 433.330K--
Nov 6, 20242024/Q31.269M / 333.330K--
Aug 6, 20242024/Q21.061M / 0.000--
May 7, 20242024/Q1986.000K / 0.000--

Unlock Free Earnings Estimates

Aligos Therapeutics Earnings Reports

Read more

Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.